Marvi

Maravai LifeSciences is a leading life sciences company that provides critical products to enable the development of novel vaccines, drug therapies, and diagnostics. The company is best known for its proprietary CleanCap technology, a global standard for co-transcriptional mRNA capping used in the production of mRNA-based vaccines and therapeutics, including major COVID-19 vaccines. Maravai operates through several specialized brands, including TriLink BioTechnologies for nucleic acid production and Cygnus Technologies for biologics safety testing. Its comprehensive portfolio supports the entire drug development lifecycle, from early-stage discovery and research to large-scale commercial manufacturing.